Skip to main content

. 1987 May;80(5):316–317. doi: 10.1177/014107688708000521

Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin.

J W Bendig, P W Kyle, P L Giangrande, D M Samson, B S Azadian

PMCID: PMC1290820 PMID: 3112380

316

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Buckner C. D., Clift R. A. Prophylaxis and treatment of infection of the immunocompromised host by granulocyte transfusions. Clin Haematol. 1984 Oct;13(3):557–572. [PubMed] [Google Scholar]
Hoogkamp-Korstanje J. A. Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy. Eur J Clin Microbiol. 1984 Aug;3(4):333–338. doi: 10.1007/BF01977489. [DOI] [PubMed] [Google Scholar]
Shrire L., Saunders J., Traynor R., Koornhof H. J. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents. Eur J Clin Microbiol. 1984 Aug;3(4):328–332. doi: 10.1007/BF01977488. [DOI] [PubMed] [Google Scholar]
Van Caekenberghe D. L., Pattyn S. R. In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives. Antimicrob Agents Chemother. 1984 Apr;25(4):518–521. doi: 10.1128/aac.25.4.518. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES